These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 23965099)

  • 1. Progressive supranuclear palsy.
    Kent A
    Nurs Stand; 2013 Aug 21-27; 27(51):48-57; quiz 58. PubMed ID: 23965099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
    Litvan I; Mangone CA; McKee A; Verny M; Parsa A; Jellinger K; D'Olhaberriague L; Chaudhuri KR; Pearce RK
    J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):615-20. PubMed ID: 8648326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive supranuclear palsy.
    Rehman HU
    Postgrad Med J; 2000 Jun; 76(896):333-6. PubMed ID: 10824045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive supranuclear palsy: where are we now?
    Burn DJ; Lees AJ
    Lancet Neurol; 2002 Oct; 1(6):359-69. PubMed ID: 12849397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history and clinical features of progressive supranuclear palsy: a clinical study.
    Diroma C; Dell'Aquila C; Fraddosio A; Lamberti S; Mastronardi R; Russo I; De Mari M; Iliceto G
    Neurol Sci; 2003 Oct; 24(3):176-7. PubMed ID: 14598074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive supranuclear palsy presenting as primary lateral sclerosis but lacking parkinsonism, gaze palsy, aphasia, or dementia.
    Nagao S; Yokota O; Nanba R; Takata H; Haraguchi T; Ishizu H; Ikeda C; Takeda N; Oshima E; Sakane K; Terada S; Ihara Y; Uchitomi Y
    J Neurol Sci; 2012 Dec; 323(1-2):147-53. PubMed ID: 23026537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
    Litvan I; Campbell G; Mangone CA; Verny M; McKee A; Chaudhuri KR; Jellinger K; Pearce RK; D'Olhaberriague L
    Brain; 1997 Jan; 120 ( Pt 1)():65-74. PubMed ID: 9055798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive supranuclear palsy.
    Amar K
    Hosp Med; 2003 Oct; 64(10):585-8. PubMed ID: 14584237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive supranuclear palsy, a case report.
    Ortiz A; Troya F; de Vera J; Vázquez E
    Arch Soc Esp Oftalmol (Engl Ed); 2024 Jul; 99(7):304-308. PubMed ID: 38768849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of a case and review of the literature].
    Trevisol-Bittencourt PC
    Arq Neuropsiquiatr; 1992 Sep; 50(3):369-74. PubMed ID: 1308417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical diagnosis and diagnostic criteria of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).
    Tolosa E; Valldeoriola F; Marti MJ
    J Neural Transm Suppl; 1994; 42():15-31. PubMed ID: 7964684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK.
    Nath U; Ben-Shlomo Y; Thomson RG; Morris HR; Wood NW; Lees AJ; Burn DJ
    Brain; 2001 Jul; 124(Pt 7):1438-49. PubMed ID: 11408338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): a short historical review.
    Pearce JM
    Neurologist; 2007 Sep; 13(5):302-4. PubMed ID: 17848869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnosis of progressive supranuclear palsy: current opinions and challenges.
    Ali F; Josephs K
    Expert Rev Neurother; 2018 Jul; 18(7):603-616. PubMed ID: 29902389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.
    Litvan I; Agid Y; Calne D; Campbell G; Dubois B; Duvoisin RC; Goetz CG; Golbe LI; Grafman J; Growdon JH; Hallett M; Jankovic J; Quinn NP; Tolosa E; Zee DS
    Neurology; 1996 Jul; 47(1):1-9. PubMed ID: 8710059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PROBABLE PROGRESSIVE SUPRANUCLEAR PALSY (STEELE-RICHARDSON- OLSZEWSKI SYNDROME): CLINICAL OBSERVATION].
    Pinchuk VA; Kryvchun A; Subbota L; Sylenko H; Pinchuk VV
    Georgian Med News; 2018 Jun; (279):87-92. PubMed ID: 30035727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and symptom management of progressive supranuclear palsy: a multidisciplinary approach.
    Ward C
    J Neurosci Nurs; 2006 Aug; 38(4):242-7. PubMed ID: 16925000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive supranuclear palsy: current approach and challenges to diagnosis and treatment.
    Veilleux Carpentier A; McFarland NR
    Curr Opin Neurol; 2023 Aug; 36(4):309-316. PubMed ID: 37381926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frontal presentation in progressive supranuclear palsy.
    Donker Kaat L; Boon AJ; Kamphorst W; Ravid R; Duivenvoorden HJ; van Swieten JC
    Neurology; 2007 Aug; 69(8):723-9. PubMed ID: 17709703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy.
    Moccia M; Picillo M; Erro R; Allocca R; Barone P; Vitale C
    J Neurol Sci; 2015 Mar; 350(1-2):103-4. PubMed ID: 25697711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.